Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 6 of 6 entries
Sorted by: Best Match Show Resources per page
Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?.

Clinical medicine insights. Ear, nose and throat

Scaglione F, Petrini O.
PMID: 30670922
Clin Med Insights Ear Nose Throat. 2019 Jan 09;12:1179550618821930. doi: 10.1177/1179550618821930. eCollection 2019.

BACKGROUND: Upper and lower respiratory tract infections are common conditions for which medical advice is sought, and their management relies on the use of prescription and over-the-counter (OTC) medicines. Ambroxol, bromhexine, carbocysteine, erdosteine, OBJECTIVE: To briefly review the evidence-based...

Cite
Scaglione F, Petrini O. Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?. Clin Med Insights Ear Nose Throat. 2019;12:1179550618821930doi: 10.1177/1179550618821930.
Scaglione, F., & Petrini, O. (2019). Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?. Clinical medicine insights. Ear, nose and throat, 121179550618821930. https://doi.org/10.1177/1179550618821930
Scaglione, Francesco, and Petrini, Orlando. "Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?." Clinical medicine insights. Ear, nose and throat vol. 12 (2019): 1179550618821930. doi: https://doi.org/10.1177/1179550618821930
Scaglione F, Petrini O. Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?. Clin Med Insights Ear Nose Throat. 2019 Jan 09;12:1179550618821930. doi: 10.1177/1179550618821930. eCollection 2019. PMID: 30670922; PMCID: PMC6328955.
Copy Download .nbib Format: NLM
Multiple fixed drug eruption due to carbocysteine: Presence of circulating interferon-γ-producing CD8.

Allergology international : official journal of the Japanese Society of Allergology

Morimoto H, Funakoshi A, Kurihara K, Shibata K, Ogura Y, Ohtsuka M, Honda T, Tokura Y.
PMID: 34635423
Allergol Int. 2021 Oct 08; doi: 10.1016/j.alit.2021.09.004. Epub 2021 Oct 08.

No abstract available.

Cite
Morimoto H, Funakoshi A, Kurihara K, et al. Multiple fixed drug eruption due to carbocysteine: Presence of circulating interferon-γ-producing CD8. Allergol Int. 2021;doi: 10.1016/j.alit.2021.09.004.
Morimoto, H., Funakoshi, A., Kurihara, K., Shibata, K., Ogura, Y., Ohtsuka, M., Honda, T., & Tokura, Y. (2021). Multiple fixed drug eruption due to carbocysteine: Presence of circulating interferon-γ-producing CD8. Allergology international : official journal of the Japanese Society of Allergology, . https://doi.org/10.1016/j.alit.2021.09.004
Morimoto, Hiroki, et al. "Multiple fixed drug eruption due to carbocysteine: Presence of circulating interferon-γ-producing CD8." Allergology international : official journal of the Japanese Society of Allergology vol. (2021). doi: https://doi.org/10.1016/j.alit.2021.09.004
Morimoto H, Funakoshi A, Kurihara K, Shibata K, Ogura Y, Ohtsuka M, Honda T, Tokura Y. Multiple fixed drug eruption due to carbocysteine: Presence of circulating interferon-γ-producing CD8. Allergol Int. 2021 Oct 08; doi: 10.1016/j.alit.2021.09.004. Epub 2021 Oct 08. PMID: 34635423.
Copy Download .nbib Format: NLM
Effect of Penetration Enhancers on Drug Nail Permeability from Cyclodextrin/Poloxamer-Soluble Polypseudorotaxane-Based Nail Lacquers.

Pharmaceutics

Cutrín-Gómez E, Anguiano-Igea S, Delgado-Charro MB, Gómez-Amoza JL, Otero-Espinar FJ.
PMID: 30551601
Pharmaceutics. 2018 Dec 13;10(4). doi: 10.3390/pharmaceutics10040273.

Nail delivery has interest for local treatment of nail diseases. Nevertheless, the low permeability of drugs in the nail plaque precludes the efficacy of local treatments. The use of penetration enhancers can increase drug permeability and improve the efficacy...

Cite
Cutrín-Gómez E, Anguiano-Igea S, Delgado-Charro MB, et al. Effect of Penetration Enhancers on Drug Nail Permeability from Cyclodextrin/Poloxamer-Soluble Polypseudorotaxane-Based Nail Lacquers. Pharmaceutics. 2018;10(4)doi: 10.3390/pharmaceutics10040273.
Cutrín-Gómez, E., Anguiano-Igea, S., Delgado-Charro, M. B., Gómez-Amoza, J. L., & Otero-Espinar, F. J. (2018). Effect of Penetration Enhancers on Drug Nail Permeability from Cyclodextrin/Poloxamer-Soluble Polypseudorotaxane-Based Nail Lacquers. Pharmaceutics, 10(4), . https://doi.org/10.3390/pharmaceutics10040273
Cutrín-Gómez, Elena, et al. "Effect of Penetration Enhancers on Drug Nail Permeability from Cyclodextrin/Poloxamer-Soluble Polypseudorotaxane-Based Nail Lacquers." Pharmaceutics vol. 10,4 (2018). doi: https://doi.org/10.3390/pharmaceutics10040273
Cutrín-Gómez E, Anguiano-Igea S, Delgado-Charro MB, Gómez-Amoza JL, Otero-Espinar FJ. Effect of Penetration Enhancers on Drug Nail Permeability from Cyclodextrin/Poloxamer-Soluble Polypseudorotaxane-Based Nail Lacquers. Pharmaceutics. 2018 Dec 13;10(4). doi: 10.3390/pharmaceutics10040273. PMID: 30551601; PMCID: PMC6321522.
Copy Download .nbib Format: NLM
Effects of a Long-Term Use of Carbocysteine on Frequency and Duration of Exacerbations in Patients with Bronchiectasis.

Open access Macedonian journal of medical sciences

Minov J, Stoleski S, Petrova T, Vasilevska K, Mijakoski D, Karadzinska-Bislimovska J.
PMID: 32165947
Open Access Maced J Med Sci. 2019 Dec 10;7(23):4030-4035. doi: 10.3889/oamjms.2019.697. eCollection 2019 Dec 15.

BACKGROUND: The failure of mucus clearance in bronchiectasis can be improved by chest physiotherapy or/and mucoactive agents.AIM: To assess the effects of long-term use of carbocysteine on frequency and duration of exacerbations in patients with bronchiectasis.METHODS: We performed an...

Cite
Minov J, Stoleski S, Petrova T, et al. Effects of a Long-Term Use of Carbocysteine on Frequency and Duration of Exacerbations in Patients with Bronchiectasis. Open Access Maced J Med Sci. 2019;7(23):4030-4035doi: 10.3889/oamjms.2019.697.
Minov, J., Stoleski, S., Petrova, T., Vasilevska, K., Mijakoski, D., & Karadzinska-Bislimovska, J. (2019). Effects of a Long-Term Use of Carbocysteine on Frequency and Duration of Exacerbations in Patients with Bronchiectasis. Open access Macedonian journal of medical sciences, 7(23), 4030-4035. https://doi.org/10.3889/oamjms.2019.697
Minov, Jordan, et al. "Effects of a Long-Term Use of Carbocysteine on Frequency and Duration of Exacerbations in Patients with Bronchiectasis." Open access Macedonian journal of medical sciences vol. 7,23 (2019): 4030-4035. doi: https://doi.org/10.3889/oamjms.2019.697
Minov J, Stoleski S, Petrova T, Vasilevska K, Mijakoski D, Karadzinska-Bislimovska J. Effects of a Long-Term Use of Carbocysteine on Frequency and Duration of Exacerbations in Patients with Bronchiectasis. Open Access Maced J Med Sci. 2019 Dec 10;7(23):4030-4035. doi: 10.3889/oamjms.2019.697. eCollection 2019 Dec 15. PMID: 32165947; PMCID: PMC7061384.
Copy Download .nbib Format: NLM
Spectrophotometric determination of cysteine and/or carbocysteine in a mixture of amino acids, shampoo, and pharmaceutical products using p-benzoquinone.

Talanta

Zaia DA, Ribas KC, Zaia CT.
PMID: 18967794
Talanta. 1999 Dec 06;50(5):1003-10. doi: 10.1016/s0039-9140(99)00218-0.

A simple, sensitive, and selective method has been developed for determination of cysteine (Cys) or carbocysteine (carboCys) in pharmaceutical products, shampoos and a mixture of amino acids. The results showed the reaction between p-benzoquinone (PBQ) and Cys occurs through...

Cite
Zaia DA, Ribas KC, Zaia CT. Spectrophotometric determination of cysteine and/or carbocysteine in a mixture of amino acids, shampoo, and pharmaceutical products using p-benzoquinone. Talanta. 1999;50(5):1003-10doi: 10.1016/s0039-9140(99)00218-0.
Zaia, D. A., Ribas, K. C., & Zaia, C. T. (1999). Spectrophotometric determination of cysteine and/or carbocysteine in a mixture of amino acids, shampoo, and pharmaceutical products using p-benzoquinone. Talanta, 50(5), 1003-10. https://doi.org/10.1016/s0039-9140(99)00218-0
Zaia, D A, et al. "Spectrophotometric determination of cysteine and/or carbocysteine in a mixture of amino acids, shampoo, and pharmaceutical products using p-benzoquinone." Talanta vol. 50,5 (1999): 1003-10. doi: https://doi.org/10.1016/s0039-9140(99)00218-0
Zaia DA, Ribas KC, Zaia CT. Spectrophotometric determination of cysteine and/or carbocysteine in a mixture of amino acids, shampoo, and pharmaceutical products using p-benzoquinone. Talanta. 1999 Dec 06;50(5):1003-10. doi: 10.1016/s0039-9140(99)00218-0. PMID: 18967794.
Copy Download .nbib Format: NLM
Classification of chronic cough by systematic treatment cascade trial starting with beta agonist.

Cough (London, England)

Shimizu H, Hayashi M, Saito Y, Mieno Y, Takeuchi Y, Sasaki F, Sakakibara H, Naito K, Okazawa M.
PMID: 23391257
Cough. 2013 Feb 07;9(1):4. doi: 10.1186/1745-9974-9-4.

BACKGROUND: Chronic cough is one of the most challenging symptoms to diagnose and treat, not only because of the variety of underlying disorders but also its varying susceptibility to treatments. Etiological studies of chronic cough vary depending on the...

Cite
Shimizu H, Hayashi M, Saito Y, et al. Classification of chronic cough by systematic treatment cascade trial starting with beta agonist. Cough. 2013;9(1):4doi: 10.1186/1745-9974-9-4.
Shimizu, H., Hayashi, M., Saito, Y., Mieno, Y., Takeuchi, Y., Sasaki, F., Sakakibara, H., Naito, K., & Okazawa, M. (2013). Classification of chronic cough by systematic treatment cascade trial starting with beta agonist. Cough (London, England), 9(1), 4. https://doi.org/10.1186/1745-9974-9-4
Shimizu, Hideyasu, et al. "Classification of chronic cough by systematic treatment cascade trial starting with beta agonist." Cough (London, England) vol. 9,1 (2013): 4. doi: https://doi.org/10.1186/1745-9974-9-4
Shimizu H, Hayashi M, Saito Y, Mieno Y, Takeuchi Y, Sasaki F, Sakakibara H, Naito K, Okazawa M. Classification of chronic cough by systematic treatment cascade trial starting with beta agonist. Cough. 2013 Feb 07;9(1):4. doi: 10.1186/1745-9974-9-4. PMID: 23391257; PMCID: PMC3602065.
Copy Download .nbib Format: NLM
Showing 1 to 6 of 6 entries